Mabano, Concepcion P.
HRN: 20-30-99 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/13/2022
MUPIROCIN 2%, 15G (TUBE)
05/13/2022
05/20/2022
LOCAL
2%
BID
Decubitus Ulcer
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes